ArticleBlood2022

Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy.

Allison Barz Leahy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.